Skip to main content
. 2021 Oct 28;45(2):468–522. doi: 10.1111/twec.13183

TABLE A3.

AstraZeneca/Oxford supply chain

Company Location Role Key dates
Oxford University Oxford, UK Identifies COVID‐19 vaccine candidate 18 March 2020
AstraZeneca Cambridge, UK Develops, manufactures, and distributes Oxford vaccine 30 April 2020
Drug substance
Oxford Biomedica Oxford, UK Signs initial clinical and commercial supply agreements 28 May 2020
Serum Institute of India (SII) Pune, India Signs licensing agreement to supply 1 billion doses to poor countries, with commitment to provide 400 million before end of 2020 4 June 2020
Emergent BioSolutions Maryland, US

Manufactures drug substance for clinical trials

Manufactures drug substance at scale

11 June 2020

27 July 2020

Catalent Maryland, US Manufactures drug substance 24 August 2020
Cobra Biologics UK Keele, UK Manufactures drug substance 16 June 2020
NovaSep (Thermo Fisher) a Seneffe, Belgium

Manufactures drug substance

Signs multiyear contract

15 June 2020

12 November 2020

mAbxience Garín, Argentina Manufactures drug substance 17 August 2020
Halix Leiden, Netherlands Manufactures drug substance 8 December 2020
Siam Bioscience Bangkok, Thailand Manufactures drug substance for Thailand and Association of Southeast Asian Nation (ASEAN) countries 12 October 2020
IDT Biologika Dessau, Germany Signs letter of intent for joint investment and capacity to manufacture drug substance 10 February 2021
CSL Broadmeadows, Australia

Manufactures drug substance

8 November 2020
JCR Pharmaceuticals Kobe, Japan

Collaboration agreement

Manufactures drug substance at new plant

August, 2020 b

March 2021 b

BioKangtai Shenzhen, China Manufactures drug substance, formulation, fill and finish for 100 million doses 21 August 2020
Fill and finish
Symbiosis Pharmaceutical Scotland Handles fill and finish for clinical trials 22 June 2020
AstraZeneca Ohio, US Handles fill and finish 11 June 2020 c
CP Pharmaceuticals (Wockhardt) Wrexham, Wales, UK Handles fill and finish 3 August 2020
Catalent Anagni, Italy Handles fill and finish 15 June 2020
Fiocruz Institute Rio de Janeiro, Brazil Handles fill and finish, eventually manufactures drug product 27 June 2020
Laboratorios Liomont Mexico Handles fill and finish for Latin American (except Brazil) 17 August 2020
CSL Parkville, Australia Handles fill and finish 8 November 2020
KM Biologics b Kumamoto prefecture, Japan Handles fill and finish 18 December 2020
Daiichi Sankyo Japan Handles fill and finish 5 February 2021
Insud Pharma Azuqueca de Henares, Guadalajara, Spain Handles fill and finish 20 January 2021
IDT Biologika Dessau, Germany Handles fill and finish 10 February 2021
a

Plant taken over by Thermo Fisher in January 2021.

b

Reported in FiercePharma.

c

Jacobs Engineering announces it is retrofitting the plant.

Source: Constructed by the authors. Hyperlinks provide original sources.